Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Brazilian Randomized Study - Impact of MRI for Breast Cancer

NCT: NCT02798796 · COMPLETED

NCT IDNCT02798796
StatusCOMPLETED
SponsorUniversity of Sao Paulo General Hospital (OTHER)
First posted
Last updated

Brief Summary

The aim of this study is to evaluate the ability of MRI to select patients for conservative treatment of breast cancer. Participants: female, over 18 years with breast cancer, stages I, II and III candidates for conservative surgery will be randomly randomized to do MRI or not according mammary density.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑